3 курс / Фармакология / Лекарственные_средства,_применяемые_в_акушерстве_и_гинекологии,
.pdfɁɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ⱦɨɩɚɦɢɧ |
3–7 |
|
ɜ/ɜ |
|
|
|
|
|
ɦɤɝ/(ɤɝ·ɦɢɧ) |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɨɛɭɬɚɦɢɧ |
2,5–10 |
|
ɜ/ɜ |
|
|
|
|
|
ɦɤɝ/(ɤɝ·ɦɢɧ) |
|
|
|
|
|
III. |
ɉɪɟɩɚɪɚɬɵ, ɭɥɭɱɲɚɸ- |
|
|
|
|
|
|
ɳɢɟ ɨɛɦɟɧɧɵɟ ɩɪɨɰɟɫɫɵ ɜ |
|
|
|
|
|
|
|
ɦɢɨɤɚɪɞɟ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɂɧɨɡɢɧ («Ɋɢɛɨɤɫɢɧ») |
20 ɦɥ |
30–60 ɦɥ |
ɜ/ɜ |
|
|
|
|
ȺɇɌɂɈɄɋɂȾȺɇɌɇȺə |
ɌȿɊȺɉɂə |
|
|
|
|
|
|
Ⱥɫɤɨɪɛɢɧɨɜɚɹ ɤɢɫɥɨɬɚ |
1–2 ɝ |
1–2 ɝ |
ɜ/ɜ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ȼɢɬɚɦɢɧ ȿ («Ɍɨɤɨɮɟ- |
0,3 ɝ |
0,3 ɝ |
ɜ/ɦ |
|
|
|
|
ɪɨɥɚ ɚɰɟɬɚɬ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɂɇȽɂȻɂɌɈɊɕ ɉɊɈɌȿɈɅɂɁȺ |
|
|
|
|
|
|
|
Ⱥɩɪɨɬɢɧɢɧ («Ƚɨɪɞɨɤɫ», |
|
200 000– |
ɜ/ɜ |
|
|
|
|
«Ʉɨɧɬɪɢɤɚɥ», «Ɍɪɚɫɢ- |
|
500 000 ȿȾ |
|
|
|
|
|
ɥɨɥ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ȺɇȺȻɈɅɂɑȿɋɄɂȿ ɉɊȿɉȺɊȺɌɕ |
|
|
|
|
|
|
|
ɇɚɧɞɪɨɥɨɧ («Ɋɟɬɚɛɨ- |
50 ɦɝ |
50 ɦɝ |
ɜ/ɦ ɱɟɪɟɡ ɞɟɧɶ |
|
|
|
|
ɥɢɥ») |
|
|
|
|
|
|
|
ɄɈɊɊȿɄɐɂə ɇȺɊɍɒȿɇɂɃ |
ɂɆɆɍɇɇɈȽɈ ɂ ɂɇɌȿɊɎȿɊɈɇɈȼɈȽɈ ɋɌȺɌɍɋȺ |
|
|||
|
|
ɂɦɦɭɧɨɝɥɨɛɭɥɢɧ ɱɟɥɨ- |
0,25–0,5 ɝ/ɤɝ |
0,25– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3 ɜɜɟɞɟɧɢɹ ɱɟɪɟɡ |
|
|
|
ɜɟɤɚ ɧɨɪɦɚɥɶɧɵɣ ɞɥɹ |
|
0,5 ɝ/ɤɝ |
|
ɫɭɬɤɢ |
|
|
|
ɜɧɭɬɪɢɜɟɧɧɨɝɨ ɜɜɟɞɟ- |
|
|
|
|
|
|
|
ɧɢɹ, ɠɢɞɤɢɣ |
|
|
|
|
|
|
|
|
|
|
|
|
|
182
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɂɧɬɟɪɮɟɪɨɧ ɚɥɶɮɚ-2 |
1 000 000 Ɇȿ |
2 000 000 |
Ɋɟɤɬɚɥɶɧɵɟ |
10 ɫɭɬ |
|
|
|
(«ȼɢɮɟɪɨɧ», «Ƚɟɧɮɟ- |
|
Ɇȿ |
ɫɜɟɱɢ |
|
|
|
|
ɪɨɧ», «Ʉɢɩɮɟɪɨɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɂɦɦɭɧɨɦɨɞɭɥɹɬɨɪɵ |
|
|
|
|
|
|
|
|
Ⱥɪɝɟɧɢɥ-ɚɥɶɮɚ- |
1 ɦɥ |
1 ɦɥ |
ɜ/ɦ |
5–10 ɫɭɬ |
|
|
|
ɚɫɩɚɪɬɢɥ-ɥɢɡɢɥ-ɜɚɥɢɥ- |
|
|
|
|
|
|
|
ɬɢɪɨɡɢɥ-ɚɪɝɟɧɢɧ |
|
|
|
|
|
|
|
(«ɂɦɭɧɨɮɚɧ») |
|
|
|
|
|
|
|
0,005% ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«Ʌɢɤɨɩɢɞ» |
0,001 ɝ |
0,002– |
ɉɨɞ ɹɡɵɤ |
10 ɫɭɬ |
|
|
|
|
|
0,003 ɝ |
|
|
|
|
|
|
0,01 ɝ |
0,2–0,3 ɝ |
ɜɧɭɬɪɶ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɪɢɛɨɧɭɤɥɟɚɬ |
0,5 ɦɥ |
0,5–1 ɦɥ |
ɜ/ɦ |
5 ɢɧɴɟɤɰɢɣ ɱɟɪɟɡ |
|
|
|
(«Ɋɢɞɨɫɬɢɧ») |
|
|
|
ɞɟɧɶ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɝɥɭɦɢɧɚ ɚɤɪɢɞɨɧ- |
0,25 ɝ |
0,25 ɝ |
ɜ/ɦ |
5 ɢɧɴɟɤɰɢɣ ɱɟɪɟɡ |
|
|
|
ɚɰɟɬɚɬ («ɐɢɤɥɨɮɟɪɨɧ») |
|
|
|
ɞɟɧɶ |
|
|
|
|
|
|
|
|
|
|
|
ȽȿɉȺɌɈɉɊɈɌȿɄɌɈɊɕ |
|
|
|
|
|
|
|
Ɏɨɫɮɨɥɢɩɢɞɵ («ɗɫ- |
10–20 ɦɥ |
10–20 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɫɟɧɰɢɚɥɟ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɞɟɦɟɬɢɨɧɢɧ («Ƚɟɩ- |
5–10 ɦɥ |
5–10 ɦɥ |
ɜ/ɜ |
|
|
|
|
|
|
|
|
|
|
183 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɬɪɚɥ») |
|
|
|
|
|
|
|
ȾɂɍɊȿɌɂɄɂ |
|
|
|
|
|
|
|
Ɏɭɪɨɫɟɦɢɞ («Ʌɚɡɢɤɫ») |
10–40 ɦɝ |
10–40 ɦɝ |
ɜ/ɜ |
|
|
|
|
ȾȿɋȿɇɋɂȻɂɅɂɁɂɊɍɘɓȺə |
ɌȿɊȺɉɂə |
|
|
|
ɉɪɢɧɢɦɚɸɬɫɹ ɞɟɫɟɧ- |
|
|
Ⱦɢɮɟɧɝɢɞɪɚɦɢɧ («Ⱦɢ- |
1 ɦɥ |
2–3 ɦɥ |
ɜ/ɦ |
10–12 ɫɭɬ |
ɫɢɛɢɥɢɡɢɪɭɸɳɢɟ Ʌɋ |
|
|
ɦɟɞɪɨɥ») 1% ɪ-ɪ |
|
|
|
|
— ɛɥɨɤɚɬɨɪɵ ɇ2- |
|
|
ɢɥɢ ɜɧɭɬɪɶ |
0,05 ɝ |
0,1 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
ɪɟɰɟɩɬɨɪɨɜ ɝɢɫɬɚɦɢɧɚ |
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɪɨɦɟɬɚɡɢɧ («Ⱦɢɩɪɚ- |
2 ɦɥ |
4 ɦɥ |
ɜ/ɦ |
10–12 ɫɭɬ |
|
|
|
ɡɢɧ», «ɉɢɩɨɥɶɮɟɧ») |
|
|
|
|
|
|
|
2,5% ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ ɜɧɭɬɪɶ |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɏɥɨɪɨɩɢɪɚɦɢɧ («ɋɭɩ- |
1 ɦɥ |
2 ɦɥ |
ɜ/ɦ |
10–12 ɫɭɬ |
|
|
|
ɪɚɫɬɢɧ») 2% ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ ɜɧɭɬɪɶ |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɛɝɢɞɪɨɥɢɧ («Ⱦɢɚɡɨ- |
0,1 ɝ |
0,2–0,3 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɥɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʉɟɬɨɬɢɮɟɧ |
0,001 ɝ |
0,002 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɏɢɮɟɧɚɞɢɧ («Ɏɟɧɤɚ- |
0,025 ɝ |
0,05– |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɪɨɥ») |
|
0,075 ɝ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʌɨɪɚɬɚɞɢɧ («Ʉɥɚɪɢ- |
0,01 ɝ |
0,01 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
|
|
|
|
|
|
184
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
ȽɅɘɄɈɄɈɊɌɂɄɈɂȾɕ |
|
|
|
|
ɉɪɢ ɝɢɩɨɬɟɧɡɢɢ |
|
|
ɉɪɟɞɧɢɡɨɥɨɧ |
0,03 ɝ |
0,03–0,09 ɝ |
ɜ/ɜ |
2–3 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɨɪɬɢɡɨɧ |
0,1–0,5 ɝ |
0,5–0,75 ɝ |
ɜ/ɜ |
2–3 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
|
ɗɍȻɂɈɌɂɄɂ |
|
|
|
|
ɉɪɟɩɚɪɚɬɵ ɞɥɹ ɩɪɨ- |
|
Ȼɢɮɢɞɭɦɛɚɤɬɟɪɢɢ, ɥɢɨɮɢɥɢɡɢɪɨɜɚɧɧɵɟ ɛɚɤɬɟɪɢɢ Lactobacillus acidophilus, Bifidobacterium |
ɮɢɥɚɤɬɢɤɢ ɢ ɥɟɱɟɧɢɹ |
|||||
|
infantis v. liberorum, Streptococcus faecium ɢ ɞɪ. |
|
|
ɞɢɫɛɚɤɬɟɪɢɨɡɚ |
|||
|
|
Ȼɢɮɢɞɨɛɚɤɬɟɪɢɢ ɛɢɮɢ- |
5 ɞɨɡ |
15 ɞɨɡ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɞɭɦ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ȼɢɮɢɞɨɛɚɤɬɟɪɢɧ ɮɨɪɬɟ |
2 ɞɨɡɵ |
6 ɞɨɡ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«ɏɢɥɚɤ ɮɨɪɬɟ» |
5 ɦɥ |
15–20 ɦɥ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«Ʌɢɧɟɤɫ» |
1 ɤɚɩɫɭɥɚ |
3 ɤɚɩɫɭɥɵ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ȻɊɈɇɏɈɅɂɌɂɄɂ |
|
|
|
|
|
|
|
Ⱥɦɢɧɨɮɢɥɥɢɧ («ɗɭ- |
20–40 ɦɥ |
20–40 ɦɥ |
ɜ/ɜ |
5–7 ɫɭɬ |
|
|
|
ɮɢɥɥɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ȺɇȺɅȿɉɌɂɄɂ |
|
|
|
|
|
|
|
ɇɢɤɟɬɚɦɢɞ («Ʉɨɪɞɢɚ- |
1–2 ɦɥ |
1–2 ɦɥ |
ɩ/ɤ |
7–10 ɫɭɬ |
|
|
|
ɦɢɧ» ) |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɋɭɥɶɮɨɤɚɦɮɨɪɧɚɹ ɤɢ- |
4–8 ɦɥ |
4–8 ɦɥ |
ɜ/ɦ |
|
|
|
|
ɫɥɨɬɚ+ɩɪɨɤɚɢɧ («ɋɭɥɶ- |
|
|
|
|
|
|
|
ɮɨɤɚɦɮɨɤɚɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
185 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
ɋɉȺɁɆɈɅɂɌɂɄɂ |
|
|
|
|
|
|
|
|
Ⱦɪɨɬɚɜɟɪɢɧ («ɇɨ-ɲɩɚ») |
2 ɦɥ |
4–8 ɦɥ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɚɩɚɜɟɪɢɧ |
2 ɦɥ |
2–4 ɦɥ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɥɚɬɢɮɢɥɥɢɧ |
1 ɦɥ |
2–3 ɦɥ |
ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɬɪɨɩɢɧ |
0,5–1 ɦɥ |
1–2 ɦɥ |
ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«Ɇɟɬɚɰɢɧ» |
0,5–1 ɦɥ |
1–2 ɦɥ |
ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɬɚɦɢɡɨɥ ɧɚɬɪɢɹ |
5–10 ɦɥ |
10–15 ɦɥ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
(«Ȼɚɪɚɥɝɢɧ Ɇ») |
|
|
|
|
|
|
|
ȽȿɆɈɋɌȺɌɂɑȿɋɄɂȿ |
ɉɊȿɉȺɊȺɌɕ |
|
|
|
Ⱦɨ ɨɫɬɚɧɨɜɤɢ ɤɪɨɜɨ- |
|
|
ɗɬɚɦɡɢɥɚɬ («Ⱦɢɰɢɧɨɧ») |
2 ɦɥ |
4–8 ɦɥ |
ɜ/ɜ |
|
ɬɟɱɟɧɢɹ |
|
|
ȺɇɌɂɉɂɊȿɌɂɄɂ |
|
|
|
|
|
|
|
«Ⱥɧɚɥɶɝɢɧ» 50% ɪ-ɪ |
2–4 ɦɥ |
4–8 ɦɥ |
ɜ/ɦ |
3–5 ɫɭɬ |
|
|
|
ɉɊȿɉȺɊȺɌɕ, ȺɄɌɂȼɂɊɍɘɓɂȿ ɈȻɆȿɇ ȼȿɓȿɋɌȼ ȼ ɌɄȺɇəɏ |
|
|
|||
|
|
«Ⱥɤɬɨɜɟɝɢɧ» |
10–20 ɦɥ |
10–20 ɦɥ |
ɜ/ɜ, ɜ/ɦ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«ɋɨɥɤɨɫɟɪɢɥ» |
5–10 ɦɥ |
5–10 ɦɥ |
ɜ/ɜ |
10–12 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
|
ȺȾɊȿɇɈɆɂɆȿɌɂɄɂ |
|
|
|
|
ɉɨ ɩɨɤɚɡɚɧɢɹɦ |
|
|
ɇɨɪɷɩɢɧɟɮɪɢɧ |
0,2–1 ɦɝ |
0,2–1 ɦɝ |
ɜ/ɜ |
|
|
|
|
ɗɎɎȿɊȿɇɌɇɕȿ ɆȿɌɈȾɕ |
Ʌȿɑȿɇɂə |
|
|
|
|
|
I. ɉɥɚɡɦɚɮɟɪɟɡ. Ⱦɥɹ ɟɝɨ ɩɪɨɜɟɞɟɧɢɹ — ɩɥɚɡɦɨɡɚɦɟɧɢɬɟɥɢ: |
|
|
||||
|
|
Ȼɟɥɤɨɜɵɟ |
|
|
|
|
|
186
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ⱥɥɶɛɭɦɢɧ 10% ɪ-ɪ |
100 ɦɥ |
100– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
|
|
200 ɦɥ |
|
|
|
|
|
Ʉɨɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
6–10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ |
|
|
|
|
|
|
|
ȽɗɄ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
|
|
|
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɨɜɢɞɨɧ 8000+ɧɚɬɪɢɹ |
200–400 ɦɥ |
200– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɯɥɨɪɢɞ+ɤɚɥɢɹ ɯɥɨ- |
|
400 ɦɥ |
|
|
|
|
|
ɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɦɚɝɧɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɝɢɞɪɨɤɚɪ- |
|
|
|
|
|
|
|
ɛɨɧɚɬ («Ƚɟɦɨɞɟɡ-ɇ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
|
|
50 000–70 000] («ɉɨɥɢ- |
|
|
|
|
|
|
|
ɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ʉɪɢɫɬɚɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɯɥɨɪɢɞ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
2–3 ɫɭɬ |
|
|
|
0,9% ɪ-ɪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
187 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ⱥɧɬɢɤɨɚɝɭɥɹɧɬɵ: |
|
|
|
|
|
|
|
Ƚɟɩɚɪɢɧ ɧɚɬɪɢɹ |
5–7500 ȿȾ |
5–7500 ȿȾ |
ɜ/ɜ |
2–3 ɫɭɬ |
|
|
II. |
Ɉɡɨɧɨɬɟɪɚɩɢɹ |
|
|
|
|
|
|
|
Ʉɪɢɫɬɚɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɯɥɨɪɢɞ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
2–3 ɫɭɬ |
|
|
|
0,9% ɪ-ɪ, |
|
|
|
|
|
|
|
ɨɛɨɝɚɳɟɧɧɵɣ ɨɡɨɧɨɦ |
|
|
|
|
|
|
|
2,5–4,0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Ɉ85 ɉɨɫɥɟɪɨɞɨ- |
ȼ |
ɚɤɭɲɟɪɫɤɨɣ ɩɪɚɤɬɢɤɟ ɋɒ |
ɜɨɡɧɢɤɚɟɬ ɤɚɤ |
ɬɹɠɟɥɟɣɲɟɟ |
ɨɫɥɨɠɧɟɧɢɟ ɩɨɫɥɟ |
ɢɧɮɢɰɢɪɨɜɚɧɧɵɯ |
ɚɛɨɪɬɨɜ, ɯɨɪɢɨɚɦɧɢɨɧɢ- |
ɜɵɣ ɫɟɩɫɢɫ |
ɬɚ, ɩɨɫɥɟɪɨɞɨɜɵɯ ɢ ɩɨɫɥɟɨɩɟɪɚɰɢɨɧɧɵɯ ɝɧɨɣɧɨ-ɜɨɫɩɚɥɢɬɟɥɶɧɵɯ ɡɚɛɨɥɟɜɚɧɢɣ, ɦɚɫɬɢɬɚ, ɩɢɟɥɨɧɟɮɪɢɬɚ. ɉɚɰɢɟɧɬɤɚɦ ɫ |
||||||
ɋɟɩɬɢɱɟɫɤɢɣ |
ɋɒ ɥɟɱɟɧɢɟ ɞɨɥɠɧɨ ɩɪɨɜɨɞɢɬɶɫɹ ɜ ɨɬɞɟɥɟɧɢɢ ɪɟɚɧɢɦɚɰɢɢ ɢ ɢɧɬɟɧɫɢɜɧɨɣ ɬɟɪɚɩɢɢ, ɬɚɤ ɤɚɤ ɨɧɢ ɧɭɠɞɚɸɬɫɹ ɜ ɩɨɫɬɨ- |
||||||
ɲɨɤ (ɋɒ) |
ɹɧɧɨɦ ɦɨɧɢɬɨɪɢɧɝɟ ɮɭɧɤɰɢɣ ɠɢɡɧɟɧɧɨ ɜɚɠɧɵɯ ɨɪɝɚɧɨɜ |
|
|
|
|||
ȼɨɡɛɭɞɢɬɟɥɢ: |
|
|
|
|
|
|
|
ȼɵɛɨɪ ɩɪɟɩɚɪɚɬɨɜ ɨɛɭ- |
|
|
|
|
Ɉɫɧɨɜɧɵɦɢ ɩɪɢɧɰɢ- |
||
E. сoli, |
ɫɥɨɜɥɟɧ ɜɨɡɛɭɞɢɬɟɥɟɦ, ɬɹ- |
|
|
|
|
ɩɚɦɢ ɥɟɱɟɧɢɹ ɩɨɫɥɟ- |
|
Proteus spp., |
ɠɟɫɬɶɸ ɢ ɥɨɤɚɥɢɡɚɰɢɟɣ |
|
|
|
|
ɪɨɞɨɜɨɝɨ ɋɒ ɹɜɥɹɸɬ- |
|
Klebsiella spp., |
ɜɨɫɩɚɥɢɬɟɥɶɧɨɝɨ ɩɪɨɰɟɫɫɚ. |
|
|
|
|
ɫɹ: ɪɚɰɢɨɧɚɥɶɧɚɹ |
|
Enterobacter |
Ⱥ. ȺɇɌɂȻɂɈɌɂɄɂ |
|
|
|
|
ɤɨɦɥɟɤɫɧɚɹ ɬɟɪɚɩɢɹ ɢ |
|
spp., |
I. Ɇɨɧɨɬɟɪɚɩɢɹ |
|
|
|
|
ɫɚɧɚɰɢɹ ɨɱɚɝɨɜ ɢɧ- |
|
Enterococcus |
|
|
1,2 ɝ |
3,6–4,8 ɝ |
ɜ/ɜ |
7–10 ɫɭɬ |
ɮɟɤɰɢɢ: ɩɪɢ ɷɧɞɨɦɟɬ- |
|
Ⱥɦɨɤɫɢɰɢɥ- |
||||||
spp., |
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
|
|
|
ɪɢɬɟ — ɜɚɤɭɭɦ- |
Bacteroides spp., |
|
ɫɥɨɬɚ («Ⱥɦɨɤɫɢɤɥɚɜ», |
|
|
|
|
ɚɫɩɢɪɚɰɢɹ ɢ ɢɧɫɬɪɭ- |
Peptostreptococ- |
|
«Ⱥɭɝɦɟɧɬɢɧ»), |
|
|
|
|
ɦɟɧɬɚɥɶɧɨɟ ɭɞɚɥɟɧɢɟ |
cus spp., |
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,375–0,625 ɝ |
1,125– |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
ɩɚɬɨɥɨɝɢɱɟɫɤɨɝɨ ɫɨ- |
ɫɬɪɟɩɬɨɤɨɤɤɢ |
|
|
|
1,875 ɝ |
|
|
ɞɟɪɠɢɦɨɝɨ ɦɚɬɤɢ; ɩɪɢ |
ɝɪɭɩɩɵ Ⱥ ɢ ȼ., |
|
ɢɥɢ |
|
|
|
|
ɩɟɪɢɬɨɧɢɬɟ — ɷɤɫ- |
Staphylococcus |
|
Ɍɢɤɚɪɰɢɥ- |
3,1 ɝ |
9,3–12,4 ɝ |
ɜ/ɜ |
7–10 ɫɭɬ |
ɬɢɪɩɚɰɢɹ ɦɚɬɤɢ ɫ ɬɪɭ- |
|
|
|
|
|
|
|
|
188
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
spp., |
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ |
|
|
|
|
ɛɚɦɢ ɢ ɞɪɟɧɢɪɨɜɚɧɢɟ |
ɚ ɬɚɤɠɟ ɚɫɫɨ- |
|
ɤɢɫɥɨɬɚ («Ɍɢɦɟɧɬɢɧ») |
|
|
|
|
ɛɪɸɲɧɨɣ ɩɨɥɨɫɬɢ; |
ɰɢɚɰɢɢ ɚɷɪɨɛ- |
|
ɢɥɢ |
|
|
|
|
ɩɪɢ ɦɚɫɬɢɬɟ — |
ɧɵɯ |
|
ɉɢɩɟɪɚɰɢɥ- |
2,25–4,5 ɝ |
6,75–13,5 ɝ |
ɜ/ɜ |
7–10 ɫɭɬ |
ɜɫɤɪɵɬɢɟ ɢ ɞɪɟɧɢɪɨ- |
ɢ ɚɧɚɷɪɨɛɧɵɯ |
|
ɥɢɧ+ɬɚɡɨɛɚɤɬɚɦ |
|
|
|
|
ɜɚɧɢɟ ɚɛɫɰɟɫɫɨɜ ɦɨ- |
ɦɢɤɪɨɨɪɝɚɧɢɡ- |
|
ɢɥɢ |
|
|
|
|
ɥɨɱɧɨɣ ɠɟɥɟɡɵ; ɩɪɢ |
ɦɨɜ |
|
ɐɟɮɨɬɚɤɫɢɦ («Ʉɥɚɮɨ- |
1,6–2 ɝ |
2–4 ɝ |
ɜ/ɜ |
7–10 ɫɭɬ |
ɩɢɟɥɨɧɟɮɪɢɬɟ — ɜɨɫ- |
|
|
ɪɚɧ»), «Ɍɚɪɰɟɮɨɤɫɢɦ») |
|
|
|
|
ɫɬɚɧɨɜɥɟɧɢɟ ɧɚɪɭ- |
|
|
ɢɥɢ |
|
|
|
|
ɲɟɧɧɨɝɨ ɩɚɫɫɚɠɚ ɦɨ- |
|
|
ɐɟɮɨɩɟɪɚɡɨɧ («ɐɟɮɨ- |
2 ɝ |
4–8 ɝ |
ɜ/ɜ, ɜ/ɦ |
7–10 ɫɭɬ |
ɱɢ (ɤɚɬɟɬɟɪɢɡɚɰɢɹ ɦɨ- |
|
|
ɛɢɞ») |
|
|
|
|
ɱɟɬɨɱɧɢɤɚ, ɧɟɮɪɨɫɬɨ- |
|
|
ɢɥɢ |
|
|
|
|
ɦɢɹ) |
|
|
ɐɟɮɬɚɡɢɞɢɦ («Ɏɨɪ- |
1–2 ɝ |
3–6 ɝ |
ɜ/ɜ |
7–10 ɫɭɬ |
|
|
|
ɬɭɦ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɐɟɮɬɪɢɚɤɫɨɧ («Ɋɨɰɟ- |
1–2 ɝ |
1–2 ɝ |
ɜ/ɜ, ɜ/ɦ |
7–10 ɫɭɬ |
|
|
|
ɮɢɧ», «ɐɟɮɬɪɢɚɛɨɥ») |
|
|
|
|
|
|
Ʉɪɨɦɟ ɬɨɝɨ, ɩɪɢ ɬɹɠɟɥɨɣ ɮɨɪɦɟ ɷɧɞɨɦɟɬɪɢɬɚ: |
|
|
|
|||
|
|
ɐɟɮɨɩɟɪɚ- |
2 ɝ |
4–8 ɝ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɡɨɧ+ɫɭɥɶɛɚɤɬɚɦ |
|
|
|
|
|
|
|
(«ɋɭɥɶɩɟɪɚɡɨɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɂɦɢɩɟɧɟɦ+ɰɢɥɚɫɬɚɬɢɧ |
0,5–1 ɝ |
2–3 ɝ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
(«Ɍɢɟɧɚɦ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɪɨɩɟɧɟɦ |
0,5–1 ɝ |
1,5–3 ɝ |
ɜ/ɜ |
5–7 ɫɭɬ |
|
|
|
|
|
|
|
|
|
189 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
(«Ɇɟɪɨɧɟɦ») |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
II. Ʉɨɦɛɢɧɢɪɨɜɚɧɧɚɹ ɬɟɪɚ- |
|
|
|
|
|
|
|
ɩɢɹ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ʉɥɢɧɞɚɦɢɰɢɧ |
0,3–0,9 ɝ |
0,9–2,7 ɝ |
ɜ/ɜ, ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʌɢɧɤɨɦɢɰɢɧ |
0,6–1,2 ɝ |
1,2–2,4 ɝ |
ɜ/ɦ, ɜ/ɜ |
5–6 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɟɬɢɥɦɢɰɢɧ |
|
4–7,5 ɦɝ/ɤɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
3–4 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ («Ɏɥɚ- |
0,5 ɝ |
1 ɝ |
ɜ/ɜ |
3–4 ɫɭɬ |
|
|
|
ɝɢɥ», «ɗɮɥɨɪɚɧ», |
|
|
|
|
|
|
|
«Ʉɥɢɨɧ») |
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ⱥɤɫɟ- |
0,75–1,5 ɝ |
2,25–4,5 ɝ |
ɜ/ɜ, ɜ/ɦ |
3–4 ɫɭɬ |
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ȾȺɅȿȿ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
3–4 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ («Ɏɥɚ- |
0,5 ɝ |
1–2 ɝ |
ɜɧɭɬɪɶ |
3–4 ɫɭɬ |
|
|
|
ɝɢɥ», «ɗɮɥɨɪɚɧ», |
|
|
|
|
|
|
|
|
|
|
|
|
|
190
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
«Ʉɥɢɨɧ») |
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ⱥɤɫɟ- |
0,5 ɝ |
1 ɝ |
ɜɧɭɬɪɶ |
3–4 ɫɭɬ |
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
|
|
Ʌɢɧɤɨɦɢɰɢɧ |
0,6 ɝ |
1,8 ɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ⱥɤɫɟ- |
0,75 ɝ |
2,25 ɝ |
ɜ/ɜ |
5–6 ɫɭɬ |
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ («Ɏɥɚ- |
0,5 ɝ |
1 ɝ |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
ɝɢɥ», «ɗɮɥɨɪɚɧ», |
|
|
|
|
|
|
|
«Ʉɥɢɨɧ») |
|
|
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,5 ɝ |
1–1,5 ɝ |
ɜɧɭɬɪɶ |
3 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ʌɟɜɨɮɥɨɤɫɚɰɢɧ («Ɍɚ- |
0,5 ɝ |
1 ɝ |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
ɜɚɧɢɤ») |
|
|
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,25–0,5 ɝ |
0,5 ɝ |
ɜɧɭɬɪɶ |
3 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɉɮɥɨɤɫɚɰɢɧ («Ɍɚɪɢ- |
0,1–0,2 ɝ |
0,2–0,4 ɝ |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
ɜɢɞ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
191 ...заболеваний инфекционных терапии при применяемые ЛС,